RBB

Paul Stoddart

Paul is a Principal in RBB’s London office. He is recognised in Who’s Who Legal as a competition expert and is a Visiting Fellow at King’s College London where he is course director of the Postgraduate Diploma in Economics for Competition Law. Paul has extensive experience on merger and abuse of dominance cases before the European Commission and UK Competition and Markets Authority.

Since starting his career in 2013, Paul has worked extensively on competition matters before the European Commission, as well as various national competition authorities and courts, including the UK, India and China. His experience spans a wide range of matters, including mergers involving both horizontal and vertical issues, abuse of dominance,anticompetitive agreements and follow-on damages litigation.

Paul is recognised in Who’s Who Legal (WWL) as a competition expert. He is course director of the Postgraduate Diploma in Economics for Competition Law at King’s College London, attended by staff from competition authorities and other leading law firms.

Paul regularly writes on a range of competition issues and his publications have featured in leading journals including European Competition Law Review and Management Science. Paul has also contributed to reports for competition authorities including “Cost pass-through: theory, measurement, and potential policy implications” (2014) published by the Office of Fair Trading.

Paul holds an MPhil in Economics from the University of Oxford and also studied Economics at the University of Warwick and the University of California, Los Angeles (UCLA).

Selected Cases

  • Qualcomm/Autotalks

    Merger, Global

  • Booking.com/eTraveli

    Merger, Global

  • Royal Mail & BT

    Litigation, UK

  • Tobii/Smartbox

    Merger, UK

  • Rentokil/Cannon

    Merger, UK

  • Essilor/Luxottica

    Merger, EU

  • Alphabet (Google)

    Google Shopping & Article 102 , EU

  • GE/Alstom

    Merger, EU

A global network of experienced experts

Our 230-strong, multi-lingual team, spread across 16 offices, has managed over 3,000 cases in 120+ countries, advising on more than one-third of EU Phase II cases in the last 5 years.